Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates
Autor: | Kan Takeda, M. Kashima, Yasuhiro Inoue, Takashi Yamanaka, Masato Kusunoki, Haruyuki Takaki, Ayumi Hamada, Koichiro Yamakado, Junji Uraki, Atsuhiro Nakatsuka |
---|---|
Rok vydání: | 2012 |
Předmět: |
Adult
Male Oncology medicine.medical_specialty Radiofrequency ablation medicine.medical_treatment Catheter ablation Gastroenterology law.invention law Internal medicine medicine Humans Radiology Nuclear Medicine and imaging Survival rate Aged Proportional Hazards Models Retrospective Studies Univariate analysis Proportional hazards model business.industry Liver Neoplasms Retrospective cohort study Middle Aged Prognosis Ablation Survival Rate Radiation therapy Treatment Outcome Catheter Ablation Disease Progression Female Colorectal Neoplasms business |
Zdroj: | Japanese Journal of Radiology. 30:567-574 |
ISSN: | 1867-108X 1867-1071 |
DOI: | 10.1007/s11604-012-0089-0 |
Popis: | To determine prognostic factors in patients with colorectal liver metastases who were not surgical candidates and received liver radiofrequency (RF) ablation. RF ablation was done for 141 colorectal liver metastases in 84 patients. There were 63 (75.0 %, 63/84) males and 21 (25.0 %, 21/84) females, with a mean age of 64.6 ± 10.3. The mean maximum tumor diameter was 2.3 ± 1.4 cm (range 0.5–9.0 cm). Extrahepatic metastases were associated at the time of liver RF ablation in 23 patients (27.4 %, 23/84), and 12 (14.3 %, 12/84) had lung metastases considered controllable by planned lung RF ablation. Prognostic factors were evaluated by univariate and multivariate analyses. There was no procedure-related mortality. The 1-, 3-, and 5-year overall survival rates were 90.6 % (95 %CI, 83.9–97.2 %), 44.9 % (95 %CI, 31.8–57.9 %), and 20.8 % (95 %CI, 7.3–34.3 %), respectively, with a median survival of 34.9 months. The univariate analysis showed that tumor diameter larger than 3 cm, tumor multiplicity, uncontrollable extrahepatic disease, and previous chemotherapy history were significantly worse prognostic factors. The former three factors remained significant for worse prognosis in the multivariate Cox model. Extrahepatic disease was not a prognostic factor when it could be controlled. Tumor size and number, and uncontrollable extrahepatic metastases were significant prognostic factors. |
Databáze: | OpenAIRE |
Externí odkaz: |